Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 7
1976 6
1977 26
1978 11
1979 21
1980 18
1981 24
1982 26
1983 35
1984 18
1985 50
1986 68
1987 57
1988 80
1989 62
1990 101
1991 84
1992 64
1993 79
1994 64
1995 62
1996 46
1997 54
1998 55
1999 37
2000 36
2001 35
2002 45
2003 46
2004 52
2005 48
2006 34
2007 45
2008 47
2009 34
2010 25
2011 25
2012 41
2013 43
2014 38
2015 21
2016 17
2017 13
2018 15
2019 8
2020 6
2021 6
2022 2
2023 7
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,792 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
Ji Y, Chen S, Yang K, Zhang X, Zhou J, Li L, Xiang B, Qiu T, Dai S, Jiang X, Lu G, Qiu L, Kong F, Zhang Y. Ji Y, et al. JAMA Otolaryngol Head Neck Surg. 2021 Jul 1;147(7):599-607. doi: 10.1001/jamaoto.2021.0454. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33856430 Free PMC article. Clinical Trial.
A total of 377 patients met the criteria for inclusion and were randomized to the propranolol (190 [50.4%]) and atenolol (187 [49.6%]) groups. Data were analyzed in June 2020. INTERVENTIONS: Participants were randomized to receive either propranolol or atenolol for …
A total of 377 patients met the criteria for inclusion and were randomized to the propranolol (190 [50.4%]) and atenolol (187 [49.6%] …
Atenolol vs nonatenolol beta-blockers for the treatment of hypertension: a meta-analysis.
Kuyper LM, Khan NA. Kuyper LM, et al. Can J Cardiol. 2014 May;30(5 Suppl):S47-53. doi: 10.1016/j.cjca.2014.01.006. Epub 2014 Jan 15. Can J Cardiol. 2014. PMID: 24750981 Free article. Review.
CONCLUSIONS: In the young, both atenolol and nonatenolol beta-blockers are effective in reducing cardiovascular end points for hypertension without compelling indications. Atenolol is associated with increased stroke in the elderly but whether this extends to nonate …
CONCLUSIONS: In the young, both atenolol and nonatenolol beta-blockers are effective in reducing cardiovascular end points for hypert …
Atenolol in essential hypertension.
Myers MG, Lewis GR, Steiner J, Dollery CT. Myers MG, et al. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):502-7. doi: 10.1002/cpt1976195part1502. Clin Pharmacol Ther. 1976. PMID: 776487 Clinical Trial.
The effect of atenolol, a beta adrenoceptor autogonist, on arterial pressure in patients with benign essential hypertension has been investigated. Eighteen patients were started on atenolol, 75 mg/day; the dose was increased at 2-wk intervals to a maximum of 900 mg …
The effect of atenolol, a beta adrenoceptor autogonist, on arterial pressure in patients with benign essential hypertension has been …
A meta-analytical comparison of atenolol with angiotensin-converting enzyme inhibitors on arterial stiffness, peripheral blood pressure and heart rate in hypertensive patients.
Xie H, Luo G, Zheng Y, Peng F, Xie L. Xie H, et al. Clin Exp Hypertens. 2017;39(5):421-426. doi: 10.1080/10641963.2016.1267188. Epub 2017 May 23. Clin Exp Hypertens. 2017. PMID: 28534649 Free article. Review.
Overall changes in PWV (weighted mean difference or WMD = 0.068, 95% confidence interval or CI: -0.487 to -0.623, P = 0.811) and peripheral systolic blood pressure (PSBP) (WMD = -1.281 mmHg, 95% CI: -6.936 to 4.375, P = 0.657) did not differ significantly between atenolol …
Overall changes in PWV (weighted mean difference or WMD = 0.068, 95% confidence interval or CI: -0.487 to -0.623, P = 0.811) and peripheral …
Atenolol eye drops.
Phillips CI, Macdonald M, Gore SM, Cullen PM. Phillips CI, et al. Br Med J. 1976 Dec 11;2(6049):1448. doi: 10.1136/bmj.2.6049.1448-b. Br Med J. 1976. PMID: 12855 Free PMC article. Clinical Trial. No abstract available.
Atenolol in hypertension: is it a wise choice?
Carlberg B, Samuelsson O, Lindholm LH. Carlberg B, et al. Lancet. 2004 Nov 6-12;364(9446):1684-9. doi: 10.1016/S0140-6736(04)17355-8. Lancet. 2004. PMID: 15530629
FINDINGS: We identified four studies that compared atenolol with placebo or no treatment, and five that compared atenolol with other antihypertensive drugs. ...Moreover, cardiovascular mortality also tended to be higher with atenolol treatment than with other …
FINDINGS: We identified four studies that compared atenolol with placebo or no treatment, and five that compared atenolol with …
Atenolol in essential hypertension during pregnancy.
Butters L, Kennedy S, Rubin PC. Butters L, et al. BMJ. 1990 Sep 22;301(6752):587-9. doi: 10.1136/bmj.301.6752.587. BMJ. 1990. PMID: 2242456 Free PMC article. Clinical Trial.
Babies in the atenolol group had a significantly lower birth weight than those in the placebo group (2620 g v 3530 g; 910 (440 to 1380)g). CONCLUSION: Atenolol given from the end of the first trimester in patients with mild hypertension is associated with intrauteri …
Babies in the atenolol group had a significantly lower birth weight than those in the placebo group (2620 g v 3530 g; 910 (440 to 138 …
Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation?
Chang SW, Gong Y, McDonough CW, Langaee TY, Nasiri Kenari N, Beitelshees AL, Gums JG, Chapman AB, Turner ST, Johnson JA, Cooper-DeHoff RM. Chang SW, et al. Clin Transl Sci. 2016 Apr;9(2):114-22. doi: 10.1111/cts.12389. Epub 2016 Mar 7. Clin Transl Sci. 2016. PMID: 26946962 Free PMC article. Clinical Trial.
Lower melatonin level, melatonin receptor gene variations, and atenolol treatment are associated with glucose dysregulation. We investigated whether atenolol-related glucose and melatonin changes are correlated, and whether single nucleotide polymorphisms (SNPs) in …
Lower melatonin level, melatonin receptor gene variations, and atenolol treatment are associated with glucose dysregulation. We inves …
Atenolol once-daily in hypertension.
Jeffers TA, Webster J, Petrie JC, Barker NP. Jeffers TA, et al. Br J Clin Pharmacol. 1977 Oct;4(5):523-7. doi: 10.1111/j.1365-2125.1977.tb00780.x. Br J Clin Pharmacol. 1977. PMID: 334211 Free PMC article. Clinical Trial.
Each patient received atenolol (50 mg/day, 100 mg/day, 200 mg/day) and placebo according to a randomized sequence in a once-daily dose. Wash-out periods on a matching placebo were included between the treatment periods. 2 The effect of lying, standing and post-exercise blo …
Each patient received atenolol (50 mg/day, 100 mg/day, 200 mg/day) and placebo according to a randomized sequence in a once-daily dos …
Atenolol and bendrofluazide in hypertension.
Petrie JC, Galloway DB, Webster J, Simpson WT, Lewis JA. Petrie JC, et al. Br Med J. 1975 Oct 18;4(5989):133-5. doi: 10.1136/bmj.4.5989.133. Br Med J. 1975. PMID: 1104047 Free PMC article. Clinical Trial.
After a four-week run-in period on matching placebo each patient received atenolol 200 mg/day, atenolol 400 mg/day, a combination of atenolol 200/mg day with bendrofluazide 5 mg/day, and bendrofluazide 5 mg/day alone, according to a random sequence. ...There …
After a four-week run-in period on matching placebo each patient received atenolol 200 mg/day, atenolol 400 mg/day, a combinat …
1,792 results

Searches related to "atenolol"